The scar treatment market is set to progress at a CAGR of 12.2% during 2024–2030, to reach USD 52.8 billion by 2030.
The major factors responsible for the growth of the market include the rising prevalence of skin diseases and burn injuries, increasing adoption of cosmetic surgeries, availability of technologically advanced scar treatment products, and surging household disposable income.
Skin diseases significantly impact the quality of life of people in developing countries by leading to loss of productivity at school work and ridicule due to disfigurement. Skin conditions with the highest prevalence are acne, scabies, pyoderma, fungal infections, tropical ulcers, AIDS-related dermatoses, and pigmentary disorders. Moreover, burn injuries are a common skin problem worldwide.
The presence of a large number of people with skin diseases and burn injuries has led to the adoption of scar treatment products and cosmetic surgeries. According to the latest ISAPS report, the volume of aesthetic/cosmetic procedures grew by 11.2% from 2021 to 2022, reaching 18.8 million non-surgical and 14.9 million surgical procedures.
The rise in the disposable income of people across the world has led to an increase in the spending on personal care, including scar removal products and devices. According to the American Academy of Dermatology (AAD), acne affects around 50 million individuals in the U.S., and the treatment and prevention cost exceeds USD 3.0 billion every year.
Moreover, according to the Bureau of Economic Analysis of the U.S., personal income increased by USD 69.5 billion (0.3% at a monthly rate) in June, and personal consumption (PCE) increased by USD 100.4 billion (0.5%). With the increase in the household disposable income, the power of individuals to spend on treating various scars also rises, thus supporting the growth of the global market.
Furthermore, according to the World Bank, the gross domestic product (GDP) per capita growth rate in China was around 3.004% in 2022 and around 6.27% in India. Thus, the expansion of the global market is fueled by the APAC population's rising spending on scar treatment.
In recent years, several technological advancements have been introduced in scar treatment solutions. Laser treatments and minimally invasive surgeries are the most-advanced treatments for scars, showing higher effectiveness, permanence, and quickness over topical ointments.
Skin problems, such as contracture scars, hypertrophic scars, keloid scars, burn scars, acne scars, post-surgical scars, and stretch marks, can be treated properly using invasive and non-invasive treatments. These treatments allow the re-organization of the cells within the scarred tissue and help in building collagen, thus healing the scars in a shorter span. Hence, the introduction of laser and minimally invasive treatments for scars acts as a key driver for the growth of the market.
The most-significant scar treatment market players are Avita Medical Inc., Revitol Corporation, Sonoma Pharmaceuticals Inc., Mölnlycke Health Care AB, CCA Industries Inc., Sisram Medical Ltd., Biodermis, Candela Corporation, Smith & Nephew plc, and Scarguard Labs LLC.